Investor directory

The Schaubroeck family is a private Belgian investor that joined TUSK IC's EUR 15M Series A in September 2026 as an existing family backer…

Pre-seed and seed investor in techbio, biotools and precision diagnostics, backing platforms where therapeutic development, diagnostics and AI are converging.

Invests in early-stage companies extending healthy lifespan ("Joyspan") across prevention, early detection and risk assessment, and smarter treatment and care delivery.

Early-stage investor partnering with founders addressing pressing global challenges, focused on supporting companies across the UK.

Gordon Sanghera is a co-founder of Oxford Nanopore Technologies, the Oxford spin-out behind nanopore DNA and RNA sequencing, which he helped build from a…

Founder-led family office backing technology companies, informed by its founders' own biotech exit to BioNTech.

Backs digital health, healthcare AI and software - care delivery tools, patient apps and health system infrastructure - typically leading or co-leading pre-seed to…

Susie Ma is the founder and CEO of Tropic Skincare, the UK beauty brand she launched in 2007 and later regained full ownership of…

Supports researcher-led spin-outs applying technology-driven medical solutions to chronic disease, providing convertible loans, vouchers and business-model support to early pre-seed teams.

Co-invests alongside private partners (minimum 50 percent private participation) in early-stage deep tech ventures across Care and Wellness, Digital Transformation, and Climate and Sustainability,…

Backs breakthrough industrial technology - robotics, semiconductors, quantum, dual-use and energy - prioritizing founders with genuine commercial execution; can follow on up to EUR…

Funds a sustainable, sovereign and digitalized European industry across Industrial Tech, Deep Tech and Climate Tech.

Backs exceptional founders building must-have solutions aligned with secular market trends, managed across the REY I, REY II and REY III seed and Series…

Backs UK disruptors and next-generation innovators; existing investor in payments company Ryft.

Point72's private credit and private equity investing division, distinct from its early-stage arm Point72 Ventures.

Global private markets investor unlocking growth beyond public markets across private equity, infrastructure, real estate and growth/venture strategies; invested here directly, not through a…

Backs early-stage B2B startups across AI infrastructure, vertical AI (healthcare, fintech, cybersecurity, education) and B2B platforms; co-manages a EUR 50M fund launched with GVC…

Early-stage venture capital investing in AI-native startups across fintech, B2B software, healthtech and the connected world, backing Italian innovators addressing global problems.

Backs transformational technology companies from early to growth stage across fintech, consumer internet, enterprise software and other emerging tech sectors.

Growth equity investor scaling high-growth businesses across AI, consumer, cybersecurity and regtech, enterprise software, fintech and healthtech.

Evaluates and selects promising Italian startups across innovation and technology sectors to connect them with its network of angel investors.

Backs ambitious Belgian tech founders at the earliest stage, even before revenue, who put their product in front of users and prove they are…